Skip to main navigation
Skip to search
Skip to main content
Arizona Board of Regents Home
Search content at Arizona Board of Regents
Home
Profiles
Departments and Centers
Scholarly Works
Grants
Activities
Equipment
Datasets
Press/Media
Prizes
The role of targeted therapy and biomarkers in breast cancer treatment
Alison T. Stopeck
, Ursa Brown-Glaberman
, Hong Yuen Wong
, Ben Ho Park
, Sara E. Barnato
, William J. Gradishar
, Clifford A. Hudis
, Hope S. Rugo
Cancer Center Division
Research output
:
Contribution to journal
›
Article
›
peer-review
40
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The role of targeted therapy and biomarkers in breast cancer treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Breast Cancer
100%
Breast Cancer Treatment
100%
Targeted Therapy
100%
Metastasis
50%
Triple-negative Breast Cancer
50%
Medical Oncology
50%
Cancer Causes
50%
Life-threatening
50%
HER2 Receptor
50%
Life Expectancy
50%
Women with Breast Cancer
50%
Early Disease
50%
Personalized Therapy
50%
Angiogenesis
50%
Metastatic Breast Cancer
50%
Cure Rate
50%
Female Cancer
50%
Treatment of Women
50%
Palliation
50%
Medicine and Dentistry
Biological Marker
100%
Breast Cancer
100%
Targeted Therapy
100%
Cancer Therapy
100%
Malignant Neoplasm
40%
Receptor
20%
Triple Negative Breast Cancer
20%
Medical Oncology
20%
Life Expectancy
20%
Symptomatic Treatment
20%
Personalized Medicine
20%
Angiogenesis
20%
Metastatic Breast Cancer
20%
Diseases
20%
Nursing and Health Professions
Biological Marker
100%
Breast Cancer
100%
Cancer Therapy
100%
Malignant Neoplasm
40%
Economic and Social Development
40%
Life Expectancy
20%
Personalized Medicine
20%
Palliative Therapy
20%
Receptor
20%
Metastatic Breast Cancer
20%
Diseases
20%
Triple Negative Breast Cancer
20%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Biological Marker
100%
Malignant Neoplasm
40%
Receptor
20%
Triple Negative Breast Cancer
20%
Life Expectancy
20%
Metastatic Breast Cancer
20%
Diseases
20%
Material Science
Targeted Therapy
100%